Subtype
Laryngeal Neoplasm
CI-CAN-00001063Explore in graph →
Non-malignant70 active trials2 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001063Explore in graph →
Clinical trials
309 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03096808 | Adaptive Radiotherapy for Head and Neck Cancer | completed | Phase 2 | 64 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 26, 2021 | clinicaltrials |
| NCT01816984 | PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 1 / Phase 2 | 12 | University of ChicagoOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT02430675 |
| Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms(IRE) |
| completed |
| N/A |
| 30 |
| Fuda Cancer Hospital, GuangzhouOTHER |
| 1 |
| Sep 5, 2021 |
| clinicaltrials |
| NCT01084733 | Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer | completed | — | 115 | Mahesh KudrimotiOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT01045057 | Clinical Feasibility of New Tracheoesophageal Puncture Set | completed | N/A | 27 | Atos Medical ABINDUSTRY | 4 | Jun 11, 2021 | clinicaltrials |
| NCT00084682 | Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 14 | National Cancer Institute (NCI)NIH | 1 | Mar 5, 2021 | clinicaltrials |
| NCT04778306 | Transoral Laser Surgery and Radiotheraphy for Early Stage Laryngeal Squamous Cell Cancer | completed | N/A | 261 | Saglik Bilimleri UniversitesiOTHER | 0 | Mar 3, 2021 | clinicaltrials |
| NCT03292341 | Evaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients.(LaDecA) | completed | N/A | 9 | Maastricht Radiation OncologyOTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT02739958 | Effects of Propofol-dexmedetomidine on Immune Function in Patients With Cancer Larynx | completed | N/A | 40 | Mansoura UniversityOTHER | 1 | Sep 22, 2020 | clinicaltrials |
| NCT04525066 | Phonosurgical Augmentation After Laser Resection of Early Glottic Carcinoma | completed | Phase 2 | 39 | Ayhman Al AfifOTHER | 0 | Aug 25, 2020 | clinicaltrials |
| NCT01314755 | A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck Cancer(IMPACTHN) | completed | N/A | 76 | Terrence JonesOTHER_GOV | 1 | Aug 7, 2020 | clinicaltrials |
| NCT03134976 | Wound Complications in Head and Neck Surgery | completed | — | 51 | University of MichiganOTHER | 1 | Jun 1, 2020 | clinicaltrials |
| NCT03132727 | Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer(Larynx MRI) | completed | — | 73 | Hospices Civils de LyonOTHER | 1 | Apr 3, 2020 | clinicaltrials |
| NCT01044433 | Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck | completed | Phase 2 | 44 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 19, 2020 | clinicaltrials |
| NCT01254617 | Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer(ADCC) | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Mar 13, 2020 | clinicaltrials |
| NCT01469429 | Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. | completed | Phase 1 / Phase 2 | 70 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Feb 20, 2020 | clinicaltrials |
| NCT01445405 | Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer | completed | Phase 1 | 3 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT01806675 | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy | completed | Phase 1 / Phase 2 | 25 | Sanjiv Sam GambhirOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT02849314 | Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer | completed | Phase 1 / Phase 2 | 30 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 12, 2019 | clinicaltrials |
| NCT00721799 | F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients | completed | Phase 2 | 33 | University of IowaOTHER | 1 | Aug 6, 2019 | clinicaltrials |
| NCT02587546 | Thulium Contact Laser of Laryngotracheal Stenosis | completed | N/A | 31 | University Hospital OstravaOTHER | 1 | Aug 1, 2019 | clinicaltrials |
| NCT02123511 | Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy | completed | Phase 2 | 34 | Mayo ClinicOTHER | 1 | Apr 30, 2019 | clinicaltrials |
| NCT00534729 | Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA | completed | N/A | 200 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Mar 1, 2019 | clinicaltrials |
| NCT00169182 | Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma | completed | Phase 3 | 220 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT02035735 | Interest of Narrow Band Imaging in Detection of Upper Aerodigestive Cancers | completed | N/A | 93 | University Hospital, ToulouseOTHER | 1 | Dec 11, 2018 | clinicaltrials |
| NCT00055913 | Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 1 / Phase 2 | 58 | National Cancer Institute (NCI)NIH | 1 | Oct 2, 2018 | clinicaltrials |
| NCT02048020 | Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer | completed | Phase 2 | 26 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 14, 2018 | clinicaltrials |
| NCT03604601 | Analysis of the Curative Effect of Salvage Surgery on Recurrent Laryngeal Carcinoma | completed | — | 54 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 0 | Jul 27, 2018 | clinicaltrials |
| NCT03585075 | Characterization of the Autofluorescence of Healthy and Pathological Tissues of Vocal Cords(FLUOROCORD) | completed | — | 30 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jul 12, 2018 | clinicaltrials |
| NCT02035527 | Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 | 3 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | May 24, 2018 | clinicaltrials |
| NCT00117572 | Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)(DeCIDE) | completed | Phase 3 | 285 | University of ChicagoOTHER | 5 | Apr 9, 2018 | clinicaltrials |
| NCT00462735 | Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer | completed | Phase 2 | 33 | Johnny KaoOTHER | 1 | Mar 13, 2018 | clinicaltrials |
| NCT01316757 | Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer | completed | Phase 2 | 24 | Fox Chase Cancer CenterOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT03010813 | A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery | completed | N/A | 63 | Chinese University of Hong KongOTHER | 1 | Feb 6, 2018 | clinicaltrials |
| NCT03357107 | Local Control After Robot-assisted Supraglottic Laryngectomy | completed | — | 122 | Hospices Civils de LyonOTHER | 1 | Nov 30, 2017 | clinicaltrials |
| NCT01435252 | A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab | completed | Phase 2 | 68 | University of ZurichOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT01700647 | Breath Testing in Early and Late Larynx Cancer | completed | — | 30 | Royal Brisbane and Women's HospitalOTHER_GOV | 1 | Sep 12, 2017 | clinicaltrials |
| NCT00359645 | Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population | completed | Phase 3 | 1,993 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT00970502 | Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer | completed | Phase 1 / Phase 2 | 15 | Johnny KaoOTHER | 1 | Apr 10, 2017 | clinicaltrials |
| NCT01256385 | Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy(MAESTRO HN) | completed | Phase 2 | 86 | National Cancer Institute (NCI)NIH | 2 | Mar 27, 2017 | clinicaltrials |
| NCT00095628 | SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Mar 6, 2017 | clinicaltrials |
| NCT02007200 | Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Oct 24, 2016 | clinicaltrials |
| NCT01089803 | Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer | completed | — | 279 | University of MinnesotaOTHER | 1 | Dec 4, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT00508664 | Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)(DeLOS II) | completed | Phase 2 | 180 | ClinAssessOTHER | 2 | Jun 2, 2015 | clinicaltrials |
| NCT00827164 | Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer | completed | Phase 2 | 29 | University of Alabama at BirminghamOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00147732 | Randomized Trial of ARCON in Larynx Cancer | completed | Phase 3 | 345 | Radboud University Medical CenterOTHER | 2 | May 7, 2015 | clinicaltrials |
| NCT00160095 | Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas | completed | — | 79 | Radboud University Medical CenterOTHER | 1 | May 7, 2015 | clinicaltrials |
| NCT00458978 | Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer | completed | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT00114283 | Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Oct 26, 2021source: clinicaltrials